MONDAY, July 14, 2025 (HealthDay News) — Men with nonmetastatic prostate cancer receiving guideline-concordant care have a much higher risk for death from causes other than prostate cancer, according to a study published online July 10 in the Journal of the National Comprehensive Cancer Network. Pietro Scilipoti, M.D. from Uppsala University in Sweden, and colleagues […]
The post Risk for Death From Prostate Cancer Low With Guideline Care for Nonmetastatic Disease first appeared on Physician’s Weekly.
